Secreted metalloproteases play a leading role in processes of tissue remodeling by initiating the degradation of extracellular matrix (ECM). This proposal outlines the plan for investigating the biological function of these proteases. The experiments described in this application are based on the hypothesis that there is interaction with fixed molecular structures on the cell surfaces and/or fibrils of the ECM. Implicit in this hypothesis is the understanding that sequestering of enzymes at such sites is required for their physiological activation. Consequently, the net extracellular enzymatic activity depends on the availability of such sites and activation conditions. The mechanistic study of such interactions has been a focus of the investigator's attention, and just recently resulted is isolation of the novel membrane bound metalloprotease MT-MMP that is responsible for cell surface activation of 72 kDa type IV collagenase (72T4Cl). Elucidation of the activation mechanism of 72T4Cl substantiates an emerging concept that metastatic invasion requires epithelial-mesenchymal cooperation. Matrix metalloproteases are expressed in vivo by stromal cells. Epithelial tumor cells express protease receptor(s) on the cell surface. Interaction between these leads to activation that is highly specific and localized, thus presenting a new target for drug development. Studies of structure-function relationships in the human 72T4Cl, particularly the function of the carboxyl-end hemopexin-like domain, will be a focus for understanding of mechanisms of enzyme activation and interaction with the specific inhibitor TIMP2. Combination of site directed mutagenesis with determination of the tertiary structure of this domain will be main approach in these studies. The investigator's success in the purification and crystallization of the recombinant carboxyl end domain will be instrumental for the success of these studies. Several promising avenues of investigation has been developed aimed at elucidation of cell surface activation mechanism of interstitial collagenase (Cl1). A newly designed experimental immunofluorescence in vitro to detect the distribution of exogenously added purified enzymes in tissue culture will be instrumental in studies of interstitial collagenase interaction with cell surface and in the development of specific competitive ligands. Data obtained from these studies will provide an understanding of the molecular mechanisms involved in regulated extracellular proteolysis and the role of ECM metalloproteases in morphogenesis wound healing and numerous pathologic conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR039472-09
Application #
2837534
Study Section
Biochemistry Study Section (BIO)
Program Officer
Tyree, Bernadette
Project Start
1989-03-01
Project End
2000-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Saffarian, Saveez; Collier, Ivan E; Marmer, Barry L et al. (2004) Interstitial collagenase is a Brownian ratchet driven by proteolysis of collagen. Science 306:108-11
Bannikov, Gregory A; Karelina, Tatiana V; Collier, Ivan E et al. (2002) Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem 277:16022-7
Collier, I E; Saffarian, S; Marmer, B L et al. (2001) Substrate recognition by gelatinase A: the C-terminal domain facilitates surface diffusion. Biophys J 81:2370-7
Strongin, A Y; Collier, I; Bannikov, G et al. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-8
Karelina, T V; Goldberg, G I; Eisen, A Z (1995) Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors. J Invest Dermatol 105:411-7
Karelina, T V; Goldberg, G I; Eisen, A Z (1994) Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia. J Invest Dermatol 103:482-7
Karelina, T V; Hruza, G J; Goldberg, G I et al. (1993) Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin. J Invest Dermatol 100:159-65
Strongin, A Y; Marmer, B L; Grant, G A et al. (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268:14033-9
Strongin, A Y; Collier, I E; Krasnov, P A et al. (1993) Human 92 kDa type IV collagenase: functional analysis of fibronectin and carboxyl-end domains. Kidney Int 43:158-62
Hasty, K A; Wu, H; Byrne, M et al. (1993) Susceptibility of type I collagen containing mutated alpha 1(1) chains to cleavage by human neutrophil collagenase. Matrix 13:181-6

Showing the most recent 10 out of 21 publications